首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Application of Hot-Melt Coating Process for Designing a Lipid Based Controlled Release Drug Delivery System for Highly Aqueous Soluble Drugs
【24h】

Application of Hot-Melt Coating Process for Designing a Lipid Based Controlled Release Drug Delivery System for Highly Aqueous Soluble Drugs

机译:热熔包衣工艺在基于脂质的高水溶性药物控释给药系统设计中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Hot-melt coating process (HMCP) was applied to develop a lipid based oral controlled release matrix system (tablet) to deliver highly aqueous soluble drugs using paracetamol as a model drug. Granules prepared from paracetamol and particular filler were coated with different levels of lipid and then compressed into tablets to get controlled/sustained delivery of the drug over an optimum period. Process parameters were optimized with particular focus on fluidization pattern during HMCP proposing a ‘design space’ with ‘Quality by Design’ (QbD) concept in mind. The results demonstrated that the granule composition influenced the drug release pattern, and the rate of release could be manipulated by varying the amount of lipid in the formulation. The in vitro release profile of the drug was pH-independent and the most promising release profile was obtained from tablets prepared from granules with the water-soluble filler, lactose, and coated at 9% (w/w) level with a lipid, glyceryl behanate. In vivo plasma profiles of the drug were predicted from the in vitro release profile data by convolution analysis which confirmed that the lactose based formulation with 9% (w/w) lipid coating on the granules would be suitable for controlled delivery of the drug over a period of 12 h making the formulation suitable for highly water soluble drug candidates like paracetamol with twice daily dose regimen. Moreover, the dissolution data adequately fitted into Higuchi model suggesting that the drug release occurred predominantly by diffusion.
机译:应用热熔包衣工艺(HMCP)开发基于脂质的口服控释基质系统(片剂),以扑热息痛为模型药物来递送高水溶性药物。由对乙酰氨基酚和特定填充剂制得的颗粒用不同水平的脂质包衣,然后压制成片剂,以在最佳时期内控制/持续递送药物。在HMCP提出“设计空间”时考虑到“设计质量”(QbD)概念,对工艺参数进行了优化,尤其侧重于流化模式。结果表明,颗粒组成影响药物释放模式,并且释放速率可以通过改变制剂中脂质的量来控制。药物的体外释放曲线与pH无关,最有希望的释放曲线是从片剂制成的,该片剂由具有水溶性填充剂乳糖的颗粒制成,并以9%(w / w)的水平涂有脂质,甘油贝那特。通过卷积分析从体外释放分布数据预测药物的体内血浆分布,这证实了在颗粒上具有9%(w / w)脂质包衣的基于乳糖的制剂将适合于在超过1分钟的时间内控制药物的递送。 12小时内使该制剂适合高水溶性药物候选物,如扑热息痛,每日两次。而且,溶出度数据完全适合Higuchi模型,表明药物释放主要通过扩散发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号